Subscribe: Market Wire - Pharmaceuticals and Biotech: Drugs
http://img.marketwire.com/rss/mwPBDR.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
announces  canada  cannabis  cfn media  company  marketwired sep  marketwired september  marketwired  media  sep  september 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Pharmaceuticals and Biotech: Drugs

Marketwired - Drugs



Marketwired - Drugs



Last Build Date: Mon, 25 Sep 2017 10:02:00 EDT

Copyright: Copyright: (C) Marketwired
 



Invictus MD: Underappreciated Among Licensed Producers - CFN Media

Mon, 25 Sep 2017 09:30:00 EDT

SEATTLE, WA--(Marketwired - Sep 25, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Invictus MD Strategies Corp. (TSX VENTURE: IMH) (OTC: IVITF), its current operations, and the fully funded near-term expansion that will greatly boost the company's production capacity.




Emerald Health Takes a Scientific Approach to Cannabis - CFN Media

Mon, 25 Sep 2017 09:22:01 EDT

SEATTLE, WA--(Marketwired - Sep 25, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing how Emerald Health Therapeutics Inc. (TSX VENTURE: EMH) (OTCQX: EMHTF) is taking a scientific approach to legal cannabis that involves developing proprietary products designed for specific medical conditions while building a Scientific Advisory Board with substantial expertise. At the same time, the company has tremendous expansion potential in a climate where many licensed producers are solely focused on increasing production capacity ahead of Canada's legalization of adult use marijuana.




Rennova Health's Labs Win Appeal in the Eleventh Circuit Court of Appeals in CIGNA Suit

Mon, 25 Sep 2017 09:20:00 EDT

WEST PALM BEACH, FL--(Marketwired - September 25, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ), a leader in diagnostic and supportive software solutions for healthcare companies, announces that it received a favorable decision from the Eleventh Circuit Court of Appeals reversing an earlier decision by the U.S. District Court.




Emerald Health Takes a Scientific Approach to Cannabis - CFN Media

Mon, 25 Sep 2017 09:03:00 EDT

SEATTLE, WA--(Marketwired - Sep 25, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing how Emerald Health Therapeutics Inc.(TSX VENTURE: EMH) (OTCQX: EMHTF) is taking a scientific approach to legal cannabis that involves developing proprietary products designed for specific medical conditions while building a Scientific Advisory Board with substantial expertise. At the same time, the company has tremendous expansion potential in a climate where many licensed producers are solely focused on increasing production capacity ahead of Canada's legalization of adult use marijuana.




BioElectronics Completes Subject Enrollment for Migraine Clinical Study; Migraine Prevention Using ActiPatch (Neuromodulation Therapy)

Mon, 25 Sep 2017 09:00:00 EDT

FREDERICK, MD--(Marketwired - Sep 25, 2017) -  BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to report on the progress of its Migraine prevention clinical study. The randomized, double-blinded, sham-controlled study involving 48 subjects is designed to investigate if ActiPatch therapy can be used to prevent the frequency and intensity of migraine attacks. Since receiving IRB-approval for the protocol in May 2017, all 48 subjects needed to complete the study have been enrolled, as of September 20th, 2017.




Pivot Pharma and Solmic Research GmbH Sign License and Collaboration Agreement for Improved Oral Formulations of Cannabinoids

Mon, 25 Sep 2017 08:30:00 EDT

VANCOUVER, BC--(Marketwired - Sep 25, 2017) - Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (Pivot or the Company) and its medical cannabis product division, Pivot Green Stream Health Solutions, today announce the signing of a Definitive Agreement with Solmic Research GmbH (Germany) in which Pivot will acquire worldwide rights to Solmic Solubilisation Technology for the development and commercialization of cannabinoid-containing natural extracts. Solmic's proprietary technology provides significantly higher bioavailability and stability compared to alternative oil-based formulations.




Scientus Pharma Granted ACMPR License From Health Canada

Mon, 25 Sep 2017 08:00:00 EDT

TORONTO, ON--(Marketwired - September 25, 2017) - HydRx Farms Ltd. (o/a Scientus Pharma) ("Scientus Pharma") is pleased to announce that it has received its Access to Cannabis for Medical Purposes Regulations ("ACMPR") license from Health Canada.

With the granting of this license, Scientus Pharma is permitted to begin cultivating medicinal cannabis at its 45,000 Sq. Ft. commercial production facility, located in Whitby, Ontario. Scientus Pharma is the 59th company in Canada to receive a cultivation license from Health Canada under the ACMPR program.




ALRT Adding International Reference Dosing to Insulin Dose Adjustment (IDA) Feature for International Market Expansion

Mon, 25 Sep 2017 08:00:00 EDT

Product development underway to add reference doses based on International Diabetes Federation, Australia, Canada, New Zealand and UK Guidelines




Food Safety: How Representative Sampling Can Reduce Your Risk, New Webinar Hosted by Xtalks

Mon, 25 Sep 2017 07:30:00 EDT

Expanding regulations, foodborne illness outbreaks, and product recalls are intensifying demand for food safety. The challenges in food production are growing more intense every year. How can you keep up?




Corbus Pharmaceuticals Announces Presentation of Three Abstracts at the 2017 North American Cystic Fibrosis Conference

Mon, 25 Sep 2017 07:00:00 EDT

NORWOOD, MA--(Marketwired - September 25, 2017) - Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that it will present three abstracts from its cystic fibrosis ("CF") research and clinical development programs at the 2017 North American Cystic Fibrosis Conference ("NACFC") being held November 2-4, in Indianapolis, IN.




Claims Substantiation - An Integrated Clinical and Regulatory Approach, New Webinar Hosted by Xtalks

Mon, 25 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 25, 2017) - During a live broadcast on Wednesday, October 11, 2017, featured speakers from Nutrasource will discuss how:




Rich Wieland Joins BioVie Management Team as Chief Financial Officer

Mon, 25 Sep 2017 07:00:00 EDT

BEVERLY, MA--(Marketwired - September 25, 2017) - BioVie Inc. (OTCQB: BIVI), a clinical-stage company focused on the discovery, development, and commercialization of innovative drug therapies for liver disease, is pleased to announce the appointment of R. Richard Wieland II, MBA as the Company's interim Chief Financial Officer.




HLS Therapeutics and Amarin Announce Agreement to Commercialize Vascepa(R) in Canada

Mon, 25 Sep 2017 06:00:00 EDT

TORONTO, CANADA, BEDMINSTER, N.J., and DUBLIN, IRELAND--(Marketwired - Sept. 25, 2017) -




HLS Therapeutics et Amarin annoncent leur entente de commercialisation de Vascepa(R) au Canada

Mon, 25 Sep 2017 06:00:00 EDT

TORONTO, CANADA, BEDMINSTER, N.J., et DUBLIN, IRLANDE--(Marketwired - 25 sept. 2017) -




Advantis Corp. Established Presence in Oregon Leads to New Contract

Sun, 24 Sep 2017 20:27:31 EDT

NEWPORT BEACH, CA--(Marketwired - Sep 24, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) is completing details on a contract with a private cannabis grower in Oregon to supply AmsterCan solutions. Advantis expects to supply the labor and canning machine to service a 40,000 square foot cultivation facility.




Rennova Health, Inc. Announces Reverse Stock Split

Fri, 22 Sep 2017 16:30:00 EDT

WEST PALM BEACH, FL--(Marketwired - September 22, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) today announced that effective at 5:00 pm, Eastern Time, on October 5, 2017 (the "Effective Time"), the Company will effect a 1 for 15 reverse stock split of its outstanding common stock. The Company's common stock will open for trading on The NASDAQ Capital Market on Friday October 6, 2017, on a post-split basis.




WeedTV.com, a Division of Player's Network, Inc., Announces Schedule for 4 Day Live Broadcast and Where to View It

Fri, 22 Sep 2017 15:29:13 EDT

The highly anticipated launch of WeedTV.com starts today with a special broadcast which provides a raw and unscripted "Behind the Scenes" look into the production of original content




The Alliance for Regenerative Medicine Submits Letter to Congress Detailing Concerns with the Senate's American Health Care Act

Fri, 22 Sep 2017 13:06:48 EDT

WASHINGTON, DC--(Marketwired - Sep 22, 2017) - The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, today sent a letter to U.S. Sens. Graham (R-SC), Cassidy, MD (R-LA), Heller (R-NV) and Johnson (R-WI), detailing concerns regarding the American Health Care Act (H.R. 1628).




The Green Organic Dutchman Announces the Hiring of New CFO and Vice President of Horticulture

Fri, 22 Sep 2017 09:41:12 EDT

HAMILTON, ON--(Marketwired - September 22, 2017) - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") is pleased to announce the hiring of a new Chief Financial Officer, Amy Stephenson, and a new Vice President of Horticulture, David Peron.




Lilly Canada et FRDJ Canada décernent des bourses de recherche postdoctorales pour la recherche sur le diabète de type 1

Fri, 22 Sep 2017 09:22:49 EDT

TORONTO, ON--(Marketwired - 22 septembre 2017) - Eli Lilly Canada Inc. (Lilly Canada) et FRDJ Canada ont décerné une bourse de recherche postdoctorale à deux chercheuses prometteuses pour poursuivre leurs travaux sur le diabète de type 1.




Lilly Canada and JDRF Canada Award Post-doctoral Fellowships in Type 1 Diabetes Research

Fri, 22 Sep 2017 09:22:00 EDT

TORONTO, ON--(Marketwired - September 22, 2017) - Eli Lilly Canada Inc. (Lilly Canada) and JDRF Canada have awarded two promising researchers each with a post-doctoral fellowship grant to pursue studies in type 1 diabetes.




Cocrystal Pharma to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference in New York

Fri, 22 Sep 2017 08:15:00 EDT

ATLANTA, GA and BOTHELL, WA--(Marketwired - Sep 22, 2017) - Cocrystal Pharma, Inc. (OTCQB: COCP) today announced that Dr. Gary Wilcox and James Martin will be presenting a company overview at the Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2017 at 8:35am in the InterContinental New York Barclay Hotel.




Overcoming the Challenges of Conducting Clinical Studies in Rare Pediatric Populations

Fri, 22 Sep 2017 08:08:27 EDT

TORONTO, ON--(Marketwired - September 22, 2017) - In an upcoming webinar on Wednesday, October 11, 2017 at 11am EDT (4pm BST/UK) experts from PRA Health Sciences including Scott Schliebner, Vice President of Rare Disease - Scientific Affairs, and Mark Sorrentino, MD, Vice President of the Center for Pediatric Clinical Development, will highlight some of the key challenges associated with conducting research within rare pediatric populations that are few in number to begin with, are geographically dispersed and are often not located near a research center.




Beware the Hidden Costs of Conducting Clinical Trials: Understanding the Landmines and How to Avoid Them

Fri, 22 Sep 2017 08:04:06 EDT

TORONTO, ON--(Marketwired - September 22, 2017) - In a complimentary webinar taking place on Wednesday, October 11, 2017 at 11am EDT (4pm BST/UK) experts from Medpace will explore four areas that can dramatically affect the cost and timelines of your clinical program and offer insight into elimination and control of these hidden landmines.




REPEAT - Cannabis Wheaton Announces Kanata Earth as First Participant in Wheaton Licensing Program and Cornerstone of Its First Nations Strategy

Fri, 22 Sep 2017 07:30:00 EDT

VANCOUVER, BC --(Marketwired - September 22, 2017) - Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) ("Cannabis Wheaton", "CW", or the "Company") welcomes Kanata Earth Inc. ("Kanata Earth") as the first participant in the recently announced Wheaton Licensing Program and the cornerstone of its First Nations strategy. Kanata Earth, rooted in the Cree word "Kanata Aski", meaning "clean soil/earth", is a First Nations-owned management company providing turnkey solutions for First Nation communities wishing to participate in the regulated cannabis industry. Kanata Earth has already submitted one application to become a licensed producer pursuant to the Access to Cannabis for Medical Purposes Regulations, with immediate plans to submit applications on behalf of another four First Nations across central and western Canada.




Cannabis Wheaton Announces Kanata Earth as First Participant in Wheaton Licensing Program and Cornerstone of Its First Nations Strategy

Fri, 22 Sep 2017 00:01:00 EDT

VANCOUVER, BC--(Marketwired - September 22, 2017) - Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) ("Cannabis Wheaton", "CW", or the "Company") welcomes Kanata Earth Inc. ("Kanata Earth") as the first participant in the recently announced Wheaton Licensing Program and the cornerstone of its First Nations strategy. Kanata Earth, rooted in the Cree word "Kanata Aski", meaning "clean soil/earth", is a First Nations-owned management company providing turnkey solutions for First Nation communities wishing to participate in the regulated cannabis industry. Kanata Earth has already submitted one application to become a licensed producer pursuant to the Access to Cannabis for Medical Purposes Regulations, with immediate plans to submit applications on behalf of another four First Nations across central and western Canada.




Health Union Launches AtopicDermatitis.net Online Community

Thu, 21 Sep 2017 14:15:00 EDT

"Atopic Dermatitis In America" Survey Reveals Patient Embarrassment, Frustration




Amazonas Florestal Ltd. Announced Today That the Company's Subsidiary Amazon Hemp Ltd. has Scheduled the Harvest of the First 100-Acre Field for Friday, September 22, 2017

Thu, 21 Sep 2017 14:12:41 EDT

MIAMI, FL--(Marketwired - Sep 21, 2017) - Amazonas Florestal, Ltd. (www.azflusa.com) (OTC PINK: AZFL), a natural resources company dedicated to innovative, sustainable forest management, industrial CBD hemp and the certification and sales of carbon credits, has announced that as of today, the Company is cleared to harvest the first 100 acre plantation. The Amazonas Florestal management team will be assisting the Amazon Hemp operatives in Colorado throughout the harvesting process, which should be taking place on Friday, September 22, 2017.




Realm Therapeutics Announces $26 Million PIPE Financing

Thu, 21 Sep 2017 13:56:47 EDT

MALVERN, PA--(Marketwired - Sep 21, 2017) - Realm Therapeutics plc (AIM: RLM), a clinical stage biopharmaceutical company focused on leveraging its proprietary immunomodulatory technology, is pleased to announce today that it has successfully secured funding commitments to raise gross proceeds of $26 million through a private placement in the United States and the United Kingdom (the "PIPE") to existing and new investors, including healthcare specialist funds OrbiMed, BVF Partners LP, RA Capital Management, Abingworth BioEquities Master Fund Ltd and Polar Capital. The PIPE is conditional upon approval of the Company's shareholders, to whom it is being presented at a General Meeting expected to be held in London on October 9, 2017, and other customary closing conditions.




Marijuana Company of America Announces Update on Hemp Growing Trials in Canada

Thu, 21 Sep 2017 13:51:01 EDT

ESCONDIDO, CA--(Marketwired - Sep 21, 2017) - MARIJUANA COMPANY OF AMERICA ("MCOA" or the "Company") (OTC PINK: MCOA), in conjunction with its joint venture partner, Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC PINK: GBHPF), is pleased to provide an update on the hemp cultivation trials conducted in New Brunswick, Canada.




AngioSoma, Inc. (OTC: SOAN) Reports Esther & Esther Confident in New Revenue Plan

Thu, 21 Sep 2017 11:33:33 EDT

HOUSTON, TX--(Marketwired - Sep 21, 2017) -  AngioSoma, Inc. (OTC: SOAN) -- Esther & Esther management has high optimism that its revenue plan could prove successful. The publicly stated plan simply and efficiently drives high volume traffic and interested buyers directly to EstherandEsther.com




Streetwise Reports Examines How Possible 'Best-in-Class' Alzheimer's Drug Candidate Offers 'Disruptive' Potential

Thu, 21 Sep 2017 08:45:00 EDT

SAN FRANCISCO, CA--(Marketwired - September 21, 2017) - André Uddin, an analyst with Mackie Research, explained the rationale for adding this neurodegenerative disease biotech company to his firm's coverage universe.




American Cannabis Company, Inc. Signs Exclusive Distribution Agreement with Earth Alive

Thu, 21 Sep 2017 08:30:00 EDT

DENVER, CO--(Marketwired - Sep 21, 2017) - American Cannabis Company, Inc. (OTCQB: AMMJ) ("ACC"), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced it has signed an exclusive distribution agreement with Earth Alive, a leading Canadian clean-tech company that develops and manufactures state-of-the-art microbial technology-based products. This agreement allows for the commercialization of Earth Alive's premiere cannabis microbial inoculant product, called Dr. Marijane. Dr. Marijane is a certified organic root probiotic that promotes increased vegetative growth, improves the bioavailability of fertilizer programs, and sustains healthy development and structuring of plant roots.




Sirona Biochem CEO's Report on Progress

Thu, 21 Sep 2017 08:00:00 EDT

VANCOUVER, BC--(Marketwired - September 21, 2017) - Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) is pleased to provide a corporate update.




Maricann Revises Convertible Debenture Terms

Thu, 21 Sep 2017 08:00:00 EDT

TORONTO, ONTARIO--(Marketwired - Sept. 21, 2017) -

NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES.




Knight to Present at the 16th Annual CIBC Eastern Institutional Investor Conference in Montreal

Thu, 21 Sep 2017 08:00:00 EDT

MONTREAL, QUEBEC--(Marketwired - Sept. 21, 2017) - Knight Therapeutics Inc. (TSX:GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that Samira Sakhia, President, is scheduled to present at the 16th Annual CIBC Eastern Institutional Investor Conference on Wednesday, September 27, 2017 at 3:25 pm ET at Le Centre Sheraton Montreal Hotel in Montreal.




Knight fera une présentation à la CIBC Eastern Institutional Investor Conference à Montréal

Thu, 21 Sep 2017 08:00:00 EDT

MONTRÉAL, QUÉBEC--(Marketwired - 21 sept. 2017) - Thérapeutique Knight inc. (TSX:GUD) (« Knight »), société pharmaceutique spécialisée et chef de file au Canada, a annoncé aujourd'hui que Samira Sakhia, présidente, présentera une mise à jour des activités de la société à la CIBC Eastern Institutional Investor Conference, le mercredi 27 septembre 2017 à 15h25 HE au Centre Sheraton Montreal Hotel à Montréal.




Pharma Competitive Intelligence: Delivering Actionable Insights for Decision Making, New Webinar Hosted by Xtalks

Thu, 21 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 21, 2017) - In a live webinar taking place on Tuesday, October 10, 2017 at 10am EDT (3pm BST/UK) industry experts Jamie Munro, Global Practice Leader of Portfolio and Licensing and Karthik Subramanian, Senior Product Strategy Manager, both from Clarivate Analytics, will provide insight into current Pharma CI, including trends and best practices.




Two Rivers Executes Amended Water Supply Agreement Doubling Potential Supply for Development

Thu, 21 Sep 2017 07:00:00 EDT

DENVER, CO--(Marketwired - Sep 21, 2017) - Two Rivers Water & Farming Company ("Two Rivers") (OTCQB: TURV) and its subsidiaries, including Water Redevelopment Company ("Water Redev") announced today it has executed a second amendment to its water supply agreement with a real estate developer, Marksheffel-Woodmen Investments, LLC and Family Ranch Holdings, LLC, (together referred to as the "Developer").




Electronic Informed Consent: 2017 Industry Survey Results from Clinical Sites, New Webinar Hosted by Xtalks

Thu, 21 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 21, 2017) - It's an exciting time for the life sciences industry, with technology driving greater levels of efficiency, effectiveness and patient engagement and satisfaction in clinical trials.




Canna Security America Rated a Top Ancillary Business by Cannabis Business Executive

Wed, 20 Sep 2017 13:31:12 EDT

DENVER, CO--(Marketwired - Sep 20, 2017) - Canna Security America (CSA) (OTCQB: CSAX), the leading comprehensive security solutions provider catering to businesses in the licensed cannabis industry, is honored to be named in Cannabis Business Executive's 2017 Top 150 Ancillary Businesses list, released early September. Listed as the #2 security solutions provider, CSA ranks #57 overall in the national directory of 150 cannabis industry ancillary companies.




First Harvest Issues Shareholder Update

Wed, 20 Sep 2017 11:47:26 EDT

Highlights Recent Developments, Milestones and New Business Opportunities




Blue Diamond Ventures Inc. Secures Canadian Real Estate Project

Wed, 20 Sep 2017 10:01:51 EDT

BLDV will build cannabis cultivation facility for Quality Green Inc. in Ontario




Sir Andrew Witty, Former CEO of GSK, Joins Synthego Advisory Board

Wed, 20 Sep 2017 09:03:00 EDT

Synthego strengthens position with appointment while accelerating worldwide commercial growth




CFN Media Exclusive Interview with United Cannabis: Developing Anti-Inflammatory Pharmaceuticals

Wed, 20 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an exclusive interview with United Cannabis Corp.'s (OTCQB: CNAB) Chief Science Officer Dr. Brent Reynolds, PhD. In the interview, Dr. Reynolds discusses the importance of clinical development and how the company's recent acquisition of Prana Therapeutics plays into its overall strategy.




True Leaf: Crowdfunding Legal Cannabis Products Across North America -- CFN Media

Wed, 20 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining True Leaf Medicine International Ltd. (CSE: MJ) (CNSX: MJ) (MJ.CN) (OTCQB: TRLFF) and its pending Regulation A+ public offering that is giving anyone the opportunity to invest in hemp and cannabis products that will be fully legal in both the U.S. and Canada. True Leaf's mission is to create safe, natural cannabis based products that enhance the quality of life for both people and pets. The company already has pet products in the market, and is in the final stages of Canadian approval to grow and sell legal cannabis.




ABcann Global Enters Its Growth Phase (Plus Exclusive Interview) -- CFN Media

Wed, 20 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an exclusive interview with ABcann Global Corporation's (TSX VENTURE: ABCN) (OTCQB: ABCCF) Aaron Keay, former CEO and current member of the Board of Directors. In the interview, Mr. Keay discusses the company's transition to new CEO Barry Fishman, as well as the opportunities ahead for the company in both Canada and internationally.




Abattis Prepares for Growth in Extracts -- CFN Media

Wed, 20 Sep 2017 08:30:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals Corp. (CSE: ATT) (ATT.CN) (CNSX: ATT) (OTCQB: ATTBF) and why its proprietary extraction technology represents an important breakthrough that shouldn't be ignored. While many licensed producers are focused on expanding capacity, the best opportunities may be those that can add value for existing licensed producers. These opportunities include those companies focused on higher value cannabis extracts.




Agritek Holdings, Inc. Announces Acquisition Of Performance Nutrition California Retail Location With eBay And Amazon Online Stores Adding In Excess Of $500,000 In Additional Gross Revenue And Product Sales For Company

Wed, 20 Sep 2017 08:30:00 EDT

LOS ANGELES, CA--(Marketwired - Sep 20, 2017) - Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com, a fully integrated, active real estate investor for the medicinal sector and branding consultant today announced that the Company has executed an Asset Purchase Agreement for the acquisition of Performance Nutrition Center, located in South Orange County, California. The Asset Purchase Agreement includes a high traffic bricks and mortar retail location within Laguna Hills, California, exclusive supplement product lines, online eBay and Amazon stores and a continuous years of product revenues as a track record of at least five-hundred thousand dollars ($500,000) in sales approaching $600,000 in product sales for 2017.




NetworkNewsWire Announces Publication Highlighting Recent Developments in Drug Delivery Technologies

Wed, 20 Sep 2017 08:30:00 EDT

NEW YORK, NY--(Marketwired - Sep 20, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a client of NNW that develops and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids.




InMed Pharma: A Leader in Cannabinoid Biosynthesis -- CFN Media

Wed, 20 Sep 2017 08:30:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering how InMed Pharmaceuticals Inc. (CSE: IN) (CNSX: IN) (IN.CN) (OTCQB: IMLFF) is leveraging biosynthesis to solve a major problem in the medical cannabis industry as it adds key ex-Eli Lilly personnel to its efforts.




Treos Bio Enters into Agreement with PPD to Manage First-in-Man Trial of Its Lead Therapeutic Cancer Vaccine Program

Wed, 20 Sep 2017 08:15:00 EDT

SAN FRANCISCO, CA and LONDON, UNITED KINGDOM--(Marketwired - Sep 20, 2017) - Treos Bio Limited, which is developing precision peptide cancer vaccines coupled with companion diagnostics, today announced it has entered into an agreement with Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization. As part of the agreement, PPD® Biotech, a PPD service dedicated to biotech and small to mid-sized pharmaceutical companies, will manage Treos Bio's first-in-man study of its lead therapeutic cancer vaccine for metastatic colorectal cancer. This study will be conducted in the United States and Europe.




Corbus Pharmaceuticals Announces Presentation of Six Abstracts and New Anabasum Data at 2017 ACR Annual Meeting

Wed, 20 Sep 2017 08:00:00 EDT

Anabasum open-label extension study interim data in systemic sclerosis to be presented




Tetra Bio-Pharma to engage in co-development and distribution partnership with major healthcare specialty distributor

Wed, 20 Sep 2017 08:00:00 EDT

OTTAWA, ONTARIO--(Marketwired - Sept. 20, 2017) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), today announced that it has signed a letter of intent (LOI) with a major player of the healthcare specialty industry.




Strategy Design & Formulation Considerations for GLP Toxicology Studies, New Webinar Hosted by Xtalks

Wed, 20 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 20, 2017) - A lack of planning for a new compound's GLP toxicology study can severely trip up your IND. Upfront planning to design a successful toxicology study, identify problems and allow time for solutions can help avoid costly delays. Toxicology study design requires a customized strategy that is relevant to the intended clinical indication and route of administration and is acceptable to regulatory authorities. Formulation development plays an important role in assessing the in-vivo properties of a molecule during preclinical development, such as overcoming solubility issues and maximizing exposure.




REPEAT - Cannabis Wheaton Announces Exclusive Distribution Alliance With Independent Pharmacy Group

Wed, 20 Sep 2017 07:30:00 EDT

VANCOUVER, BC--(Marketwired - September 20, 2017) - Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) ("Cannabis Wheaton", "CW", or the "Company") is happy to announce that it has entered an exclusive distribution alliance with the corporate owner of a national chain of independent pharmacies (the "Pharmacy Group") to develop and implement medical cannabis distribution and retail sale opportunities at all Pharmacy Group locations (collectively, the "Responsible Retailing Program").




Next Generation Data Mapping and Analytics Solutions Improve the Speed and Quality of Preparing Data Submissions for FDA, New Webinar Hosted by Xtalks

Wed, 20 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 20, 2017) - FDA now requires drug development firms pursuing approvals to submit all clinical data in CDISC standards such as the Study Data Tabulation Model (SDTM). To meet this requirement, many companies are using labor-intensive, manual and error-prone data extraction and mapping techniques.




Cannabis Wheaton Announces Exclusive Distribution Alliance With Independent Pharmacy Group

Wed, 20 Sep 2017 00:01:00 EDT

VANCOUVER, BC--(Marketwired - September 20, 2017) - Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) ("Cannabis Wheaton", "CW", or the "Company") is happy to announce that it has entered an exclusive distribution alliance with the corporate owner of a national chain of independent pharmacies (the "Pharmacy Group") to develop and implement medical cannabis distribution and retail sale opportunities at all Pharmacy Group locations (collectively, the "Responsible Retailing Program").




Dr. Patrick M. Fratellone Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor

Tue, 19 Sep 2017 10:30:00 EDT

HICKSVILLE, NY--(Marketwired - Sep 19, 2017) - Canbiola, Inc. (OTC PINK: CANB) announced today that the company has added Dr. Fratellone to its Medical Advisory Board and engaged Dr. Fratellone as a distributor for Canbiola products. Dr. Fratellone is an attending physician at St. Luke's Hospital, Roosevelt Hospital, and Beth Israel Hospital, and current professor at University of Bridgeport College of Naturopathic Medicine. In addition, he bridges East Meets West at the Center of Excellence in Bridgeport CT with author Dr. Peter D'Adamo of Eat Right for Your Blood Type. Dr. Fratellone has appeared on multiple shows, and is considered an expert in his field as well a visionary. Dr. Fratellone stated, "As one of the few MDs in the US who is also a registered herbalist, I believe in traditional and time honored treatments, but also to look outside of the box; to that end CBD is certainly part of the future in my opinion with clear benefits to patients. I look forwarded to working with Canbiola, as well as educating the public on the vast benefits of CBD through blogs and speaking engagements."




FDA Grants ALRT Clearance for Insulin Dose Adjustment (IDA) Feature

Tue, 19 Sep 2017 10:02:29 EDT

IDA is designed to ensure that patients get an effective and timely insulin dose(s) based on accurate data about their specific needs




Avadim Technologies Inc. Announces Partnership With Cardinal Health, Inc.

Tue, 19 Sep 2017 09:15:00 EDT

Cardinal Health, a Global, Integrated Healthcare Services and Products Company Ranked #15 of Fortune 500 Companies, Will Now Supply Theraworx(R) Technology to its Acute Care and Long-Term Care Customers




Pivot Pharma Looks to Improve Cannabinoid Bioavailability with Topical BiPhasix(TM) Delivery System -- CFN Media

Tue, 19 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 19, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) and its recent acquisition of the BiPhasixT Transdermal Drug Delivery technology for the delivery of cannabinoids.




Medovex Corporation Launches DenerveX System in Spain with Distributor Prim SA

Tue, 19 Sep 2017 08:30:00 EDT

Training and First Order Scheduled for Week of September 19th




Rennova Health Announces Big South Fork Medical Center Provided Services to Over 1,000 Patients in First Month of Operation

Tue, 19 Sep 2017 08:30:00 EDT

WEST PALM BEACH, FL--(Marketwired - September 19, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces that Big South Fork Medical Center's Emergency Room has received 1,005 visits in its first month of operation and admitted 45 patients for overnight stays.




Cannabis Science "Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids" Full Publication Released Today In Frontiers In Oncology

Tue, 19 Sep 2017 08:18:05 EDT

IRVINE, CA--(Marketwired - Sep 19, 2017) -  Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces the full publication of initial research results on using nanoparticle drones to target lung cancer with radiosensitizers and cannabinoids in the world-renowned cancer research journal, Frontiers in Oncology, released today.




Graybug Vision Initiates Phase 1/2 Trial of GB-102 for Wet Age-related Macular Degeneration

Tue, 19 Sep 2017 08:00:00 EDT

Novel Injectable Formulation for Potential Twice Per Year Treatment




American Green Successfully Completes Transaction for the Purchase of Nipton, CA, Ahead of Schedule

Tue, 19 Sep 2017 08:00:00 EDT

After Completing Its Due Diligence, Company Now Begins Transforming Nipton Into a Legal, Cannabis-Friendly Town




Pharmacology to Payer: One Quantitative Drug Development Framework to Rule Them All

Tue, 19 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 19, 2017) - This webinar will discuss how "pharmacology to payer" (P2P) can be used as a quantitative framework that bridges the disciplines of pharmacology, epidemiology, and health economics to support meaningful dialogue between industry, regulators, and payers.




Biologics in Dermatology: Considerations for Patients and Clinical Trials, New Webinar Hosted by Xtalks

Tue, 19 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 19, 2017) - In an upcoming presentation experts Darcee Duke Strube, Senior Vice President of Novella Clinical's Dermatology Division and Dr. James J Milbauer, Dermatologist, Medical Monitor and Advisor will discuss the evolution of biologics within the dermatology landscape, with an emphasis on clinical trial considerations for sponsors developing biologic agents.




Revive Therapeutics and South Carolina Research Foundation Enter into Exclusive License Agreement for Cannabinoids-Based Therapeutics in the Treatment of Liver Diseases

Tue, 19 Sep 2017 07:00:00 EDT

TORONTO, ONTARIO--(Marketwired - Sept. 19, 2017) - Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE:RVV)(OTCQB:RVVTF), a company focused on the research, development and commercialization of novel treatments for serious and unmet medical needs, today announced that it has entered into a license agreement with South Carolina Research Foundation ("SCRF"), under which Revive will acquire an exclusive license from SCRF to develop and commercialize a portfolio of patents based on cannabinoid-based therapeutics, such as Cannabidiol, in the treatment of liver diseases.




Hydropothecary announces kosher certification on processed medical marijuana products

Tue, 19 Sep 2017 03:00:00 EDT

GATINEAU, QC--(Marketwired - September 19, 2017) - The Hydropothecary Corporation ("THCX" or the "Company") (TSX VENTURE: THCX) is pleased to announce its processed medical marijuana products have been granted kosher certification by the Ottawa Vaad HaKashrut. It is the only kosher certification currently granted to cannabis products in Canada.




Hydropothecary annonce la certification casher de produits transformés de marijuana médicale

Tue, 19 Sep 2017 03:00:00 EDT

GATINEAU, QC--(Marketwired - 19 septembre 2017) - La société Hydropothecary (" THCX " ou la " Société ") (TSX CROISSANCE: THCX) a le plaisir d'annoncer que ses produits transformés de marijuana médicale ont reçu la certification casher de Vaad HaKashrut, à Ottawa. C'est actuellement la seule instance d'une certification casher à être accordée à des produits de cannabis au Canada.




Industry Leader, Darren Cherry, Leads Advantis Corp. Into the Future

Tue, 19 Sep 2017 01:53:03 EDT

NEWPORT BEACH, CA--(Marketwired - Sep 19, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) announced that it has agreed with leading wholesale, marketing, and logistics expert, Darren Cherry, to take the helm as its new CEO.




Cannabis Wheaton Announces Private Placement of Convertible Debenture Units

Mon, 18 Sep 2017 23:08:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 18, 2017) -




FRDJ et la Financière Sun Life font équipe pour amasser des fonds destinés à la recherche sur le diabète

Mon, 18 Sep 2017 16:33:42 EDT

La Révolution FRDJ Roulons met les Canadiens au défi de se dépasser et de récolter de l'argent pour vaincre le diabète de type 1




JDRF and Sun Life Financial team up to raise funds for diabetes research

Mon, 18 Sep 2017 16:33:07 EDT

The JDRF Revolution Ride challenges Canadians to go further and raise funds to defeat type 1 diabetes